Cargando…

Ambroxol - Resurgence of an old molecule as an anti-inflammatory agent in chronic obstructive airway diseases

Detalles Bibliográficos
Autor principal:	Gupta, P. R.
Formato:	Texto
Lenguaje:	English
Publicado:	Medknow Publications 2010
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893422/ https://www.ncbi.nlm.nih.gov/pubmed/20616932 http://dx.doi.org/10.4103/0970-2113.63603

Ejemplares similares

Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation
por: Takeda, Katsuyuki, et al.
Publicado: (2016)

Repurposing the mucolytic agent ambroxol for treatment of sub-acute and chronic ischaemic stroke
por: Patzwaldt, Kristin, et al.
Publicado: (2023)

In Chronic Obstructive Pulmonary Disease Progression, Is It Airway Narrowing or Airway Loss?
por: Rizi, Rahim R., et al.
Publicado: (2021)

Resurgence of Conservative treatment
por: Antao, Nicholas, et al.
Publicado: (2020)

Use of Ambroxol as Therapy for Gaucher Disease
por: Zhan, Xia, et al.
Publicado: (2023)

State of the Globe: The Resurgence of Vivax
por: Chauhan, Vivek, et al.
Publicado: (2016)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

Taking Small Airways in Chronic Obstructive Pulmonary Disease to TASC
por: Sauler, Maor, et al.
Publicado: (2023)

Extrapulmonary tuberculosıs: an old but resurgent problem
por: Baykan, Ali H., et al.
Publicado: (2022)

Old Cells in Young Airway Smooth Muscle: Does Neonatal Senescence Cause Lifelong Airway Obstruction?
por: Sasse, Sarah K., et al.
Publicado: (2019)

Malaria Resurgence in the Americas: An Underestimated Threat
por: Espinoza, J. Luis
Publicado: (2019)

Resurgence of COVID-19 and diabetes in India
por: Pal, Rimesh, et al.
Publicado: (2021)

Asthma, bronchiectasis, and chronic obstructive pulmonary disease: the Bermuda Triangle of the airways
por: Martínez García, Miguel Ángel, et al.
Publicado: (2022)

Resurgence of non-communicable diseases in LMICs: a cause for concern?
por: Tumwine, James K
Publicado: (2019)

The new COVID-19 poor and the neglected tropical diseases resurgence
por: Hotez, Peter J., et al.
Publicado: (2021)

Biodegradable Chitosan-Based Ambroxol Hydrochloride Microspheres: Effect of Cross-Linking Agents
por: Gangurde, HH, et al.
Publicado: (2011)

Association Between Ambroxol at the Usual Dose and the Risk of Parkinson’s Disease in Chronic Lung Disease
por: Kim, Min Seung, et al.
Publicado: (2023)

Calming Nervous Airways: Targeted Lung Denervation for Chronic Obstructive Pulmonary Disease
por: Aaron, Shawn D., et al.
Publicado: (2019)

Typhoid Fever: A Reduction and a Resurgence
por: Meiring, James E., et al.
Publicado: (2023)

Inhibition of inflammatory responses by ambroxol, a mucolytic agent, in a murine model of acute lung injury induced by lipopolysaccharide
por: Su, Xiao, et al.
Publicado: (2004)

Measles Resurgence in Europe: An Open Breakthrough in the Field of Vaccine-Preventable Diseases
por: De Francesco, Maria Antonia
Publicado: (2023)

Physostigmine in Anticholinergic Poisoning: An Old Antidote With Resurgence
por: Blackstone, Nicholas G, et al.
Publicado: (2020)

Ambroxol for the treatment of fibromyalgia: science or fiction?
por: Kern, Kai-Uwe, et al.
Publicado: (2017)

Value of ambroxol in the treatment of asthmatic bronchitis
por: Du, Xiaoxia, et al.
Publicado: (2020)

Polypharmacology of ambroxol in the treatment of COVID-19
por: Wang, Ziyuan, et al.
Publicado: (2023)

Premature Aging of the Airway Epithelium in Chronic Obstructive Pulmonary Disease in People Living with HIV
por: Kaner, Robert J.
Publicado: (2022)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

How we can prevent a resurgence this year
por: Lee, Jong-Koo
Publicado: (2023)

Proteoglycans in Biomedicine: Resurgence of an Underexploited Class of ECM Molecules
por: Walimbe, Tanaya, et al.
Publicado: (2020)

Airway Basal Cells in Chronic Obstructive Pulmonary Disease: A Continuum or a Dead End?
por: Shaykhiev, Renat
Publicado: (2021)

Inhaled Antibiotics and Airway Bacterial Decolonization for Patients with Chronic Obstructive Pulmonary Disease: The Rationale and Future
por: Han, Yaopin, et al.
Publicado: (2022)

Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
por: Bendikov-Bar, Inna, et al.
Publicado: (2013)

Artificial intelligence and machine learning: the resurgence of the industrial revolution by robots
por: Alasnag, Manal, et al.
Publicado: (2022)

Resurgence?
por: Mann, Douglas L.
Publicado: (2021)

Inflammatory Endotype-Associated Airway Resistome in Chronic Obstructive Pulmonary Disease
por: Yi, Xinzhu, et al.
Publicado: (2022)

Innate Immune Reprogramming in Chronic Obstructive Pulmonary Disease: New Mechanisms for Old Questions
por: Kim, Richard Y., et al.
Publicado: (2023)

Ambroxol hydrochloride in the management of idiopathic pulmonary fibrosis: Clinical trials are the need of the hour
por: Gupta, P. R.
Publicado: (2014)

The Ongoing — and Resurgent — Challenge of Post-Infarct Ventricular Septal Defect Management
por: Goldberg, Steven L., et al.
Publicado: (2020)

Resurgence of sport in the wake of COVID-19: cardiac considerations in competitive athletes
por: Baggish, Aaron, et al.
Publicado: (2020)

An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children
por: Kantar, Ahmad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1v96qt0v5uihjl8akjm7q5j0n9